Catherine E. Willoughby
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Cancer Genomics and Diagnostics
Papers in
- Oncology 3
- Inflammatory Biomarkers in Disease Prognosis 1
- Pancreatic and Hepatic Oncology Research 1
- Cancer Cells and Metastasis 1
-
- Hepatocellular Carcinoma Treatment and Prognosis 2
- Liver physiology and pathology 2
- Co-authors
- Josep M. Llovet (5 shared papers)Scott L. Friedman (2 shared papers)Hashem B. El‐Serag (1 shared paper)Amit G. Singal (1 shared paper)Tim F. Greten (1 shared paper)Richard S. Finn (1 shared paper)Mathias Heikenwälder (1 shared paper)Laura Ogle (3 shared papers)
- Journals
- Clinical Cancer Research (2 papers)Journal of Hepatology (2 papers)Hepatology (1 paper)Nature Reviews Gastroenterology & Hepatology (1 paper)British Journal of Cancer (1 paper)
- Partner nations
- United StatesSpainUnited Kingdom
In The Last Decade
Catherine E. Willoughby
9 papers receiving 695 citations
Catherine E. Willoughby's Hit Papers
Peers
Comparison fields: 5 of 67
- Hepatology 192
- Cancer Research 122
- Oncology 207
- Epidemiology 158
- Immunology 76
Countries citing papers authored by Catherine E. Willoughby
This map shows the geographic impact of Catherine E. Willoughby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine E. Willoughby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine E. Willoughby more than expected).
Fields of papers citing papers by Catherine E. Willoughby
This network shows the impact of papers produced by Catherine E. Willoughby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine E. Willoughby. The network helps show where Catherine E. Willoughby may publish in the future.
Co-authors
The 25 scholars most cited alongside Catherine E. Willoughby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment Hit paper breakdown → | 2023 | 223 |
| 2 | 2021 | 112 | |
| 3 | 2016 | 101 | |
| 4 | 2020 | 78 | |
| 5 | 2014 | 71 | |
| 6 | 2017 | 69 | |
| 7 | 2020 | 41 | |
| 8 | 2020 | 6 | |
| 9 | 2001 | 2 |
About Catherine E. Willoughby
Catherine E. Willoughby is a scholar working on Oncology, Hepatology, Surgery, Clinical Psychology and Epidemiology, having authored 9 papers that have together received 703 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Liver physiology and pathology (2 papers), Inflammatory Biomarkers in Disease Prognosis (1 paper), Pancreatic and Hepatic Oncology Research (1 paper), Poisoning and overdose treatments (1 paper), Cancer Cells and Metastasis (1 paper), Endoplasmic Reticulum Stress and Disease (1 paper) and Suicide and Self-Harm Studies (1 paper). The work is most often cited by research in Hepatology (192 citations), Cancer Research (122 citations), Oncology (207 citations), Epidemiology (158 citations) and Immunology (76 citations). Catherine E. Willoughby has collaborated with scholars based in United States, Spain and United Kingdom. Frequent co-authors include Josep M. Llovet, Scott L. Friedman, Hashem B. El‐Serag, Amit G. Singal, Tim F. Greten, Richard S. Finn, Mathias Heikenwälder, Laura Ogle, Helen L. Reeves and Laura Torrens. Their work appears in journals such as Clinical Cancer Research, Journal of Hepatology, Hepatology, Nature Reviews Gastroenterology & Hepatology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.